These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34526783)

  • 1. Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index.
    Daley-Yates PT; Larenas-Linnemann D; Bhargave C; Verma M
    J Asthma Allergy; 2021; 14():1093-1104. PubMed ID: 34526783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of intranasal corticosteroid formulations for the treatment of allergic rhinitis.
    Wingertzahn MA; Derebery MJ; Nelson HS
    Allergy Asthma Proc; 2007; 28 Suppl 1():S18-24. PubMed ID: 18307840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal corticosteroids in the treatment of allergic rhinitis.
    Ratner PH; Stoloff S; Meltzer EO; Hadley JA
    Allergy Asthma Proc; 2007; 28 Suppl 1():S25-32. PubMed ID: 18307841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of intranasal corticosteroids.
    Bensch GW
    Ann Allergy Asthma Immunol; 2016 Dec; 117(6):601-605. PubMed ID: 27979016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of intranasal corticosteroids for allergic rhinitis in children.
    Zhang M; Ni JZ; Cheng L
    Expert Opin Drug Saf; 2022 Jul; 21(7):931-938. PubMed ID: 35199623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids.
    Karaki M; Akiyama K; Mori N
    Auris Nasus Larynx; 2013 Jun; 40(3):277-81. PubMed ID: 23127728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming barriers to intranasal corticosteroid use in patients with uncontrolled allergic rhinitis.
    Bridgeman MB
    Integr Pharm Res Pract; 2017; 6():109-119. PubMed ID: 29354557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciclesonide, a hypotonic intranasal corticosteroid.
    Neffen H; Wingertzahn MA
    Allergy Asthma Proc; 2010; 31 Suppl 1():S29-37. PubMed ID: 20557684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled corticosteroids: potency, dose equivalence and therapeutic index.
    Daley-Yates PT
    Br J Clin Pharmacol; 2015 Sep; 80(3):372-80. PubMed ID: 25808113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General practitioner and patient perspectives on intranasal corticosteroids for allergic rhinitis: Treatment duration and obstacles to adherence, findings from a recent survey.
    Larenas-Linnemann DES; Domthong P; Di Francesco RC; González-Pérez R; Verma M
    World Allergy Organ J; 2024 Jul; 17(7):100925. PubMed ID: 39035787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis.
    Wu EL; Harris WC; Babcock CM; Alexander BH; Riley CA; McCoul ED
    Otolaryngol Head Neck Surg; 2019 Jul; 161(1):18-27. PubMed ID: 30779679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal antihistamine is superior to oral H
    Du K; Qing H; Zheng M; Wang X; Zhang L
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
    Lohia S; Schlosser RJ; Soler ZM
    Allergy; 2013; 68(5):569-79. PubMed ID: 23590215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Children.
    Donaldson AM; Choby G; Kim DH; Marks LA; Lal D
    Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1087-1096. PubMed ID: 32660332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intranasal corticosteroids.
    Szefler SJ
    J Allergy Clin Immunol; 2001 Jul; 108(1 Suppl):S26-31. PubMed ID: 11449203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis.
    Seresirikachorn K; Chitsuthipakorn W; Kanjanawasee D; Khattiyawittayakun L; Snidvongs K
    Int Forum Allergy Rhinol; 2018 Oct; 8(10):1083-1092. PubMed ID: 29917324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of treatments for allergic rhinitis in children.
    Baena-Cagnani CE
    Drug Saf; 2004; 27(12):883-98. PubMed ID: 15366976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology, particle deposition and drug administration techniques of intranasal corticosteroids for treating allergic rhinitis.
    Rollema C; van Roon EN; van Boven JFM; Hagedoorn P; Klemmeier T; Kocks JH; Metting EI; Oude Elberink HNG; Peters TTA; San Giorgi MRM; de Vries TW
    Clin Exp Allergy; 2022 Nov; 52(11):1247-1263. PubMed ID: 35947495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases.
    Smith P; Price D; Harvey R; Carney AS; Kritikos V; Bosnic-Anticevich SZ; Christian L; Skinner D; Carter V; Durieux AMS
    J Asthma Allergy; 2017; 10():153-161. PubMed ID: 28533689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Intranasal Corticosteroid Sensory Attributes and Patient Preference for Fluticasone Furoate for the Treatment of Allergic Rhinitis.
    May JR; Dolen WK
    Clin Ther; 2019 Aug; 41(8):1589-1596. PubMed ID: 31402060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.